Table 2.
Comparison of clinical orientation of participants after cadaveric and endoscopic exposure
| Category | Sub category | POST | p Value | |
|---|---|---|---|---|
| Cadaveric | Endoscopic | |||
| Anterior skull base | Q7 | 19.4 | 52.2 | 0.0040 |
| Q8 | 51.6 | 91.3 | 0.0001 | |
| Q9 | 38.7 | 34.8 | 0.7270 | |
| Lacrimal | Q7 | 16.7 | 86.7 | < 0.001 |
| Q8 | 16.7 | 38.3 | 0.0369 | |
| Q9 | 50.0 | 50.0 | 1.000 | |
| Nasal | Q7 | 56.7 | 78.7 | 0.0289 |
| Q8 | 30.0 | 75.4 | < 0.001 | |
| Q9 | 33.3 | 86.9 | < 0.001 | |
| Orbit | Q7 | 25.0 | 64.7 | 0.0001 |
| Q8 | 40.0 | 39.2 | 0.9380 | |
| Q9 | 40.0 | 64.7 | 0.0190 | |
| Paranasal | Q7 | 46.7 | 26.3 | 0.0550 |
| Q8 | 26.7 | 63.2 | 0.0012 | |
| Q9 | 13.3 | 49.1 | 0.0010 | |
| Anterior skull base | Q10 | 80.6 | 87.0 | 0.4480 |
| Lacrimal | 83.3 | 85.0 | 0.8340 | |
| Nasal | 90.0 | 88.5 | 0.8300 | |
| Orbit | 87.5 | 82.4 | 0.5328 | |
| Paranasal | 83.3 | 84.2 | 0.9130 | |
Significant p values are highlighed in bold